Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company was founded in 2007 and is headquartered in Maple Grove, Minnesota.
Industry, Sector and Symbol
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
PhoneN/A
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date6/6/2019 (Estimated)
OptionableOptionable
Inspire Medical Systems (NASDAQ:INSP) Frequently Asked Questions
What is Inspire Medical Systems' stock symbol?
Inspire Medical Systems trades on the NASDAQ under the ticker symbol "INSP."
How were Inspire Medical Systems' earnings last quarter?
Inspire Medical Systems (NASDAQ:INSP) posted its earnings results on Tuesday, February, 26th. The company reported ($0.22) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.32) by $0.10. The firm earned $16.56 million during the quarter, compared to analyst estimates of $15.42 million. The company's quarterly revenue was up 66.3% on a year-over-year basis. View Inspire Medical Systems' Earnings History.
When is Inspire Medical Systems' next earnings date?
What guidance has Inspire Medical Systems issued on next quarter's earnings?
Inspire Medical Systems issued an update on its FY 2019 earnings guidance on Tuesday, February, 26th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $67-70 million, compared to the consensus revenue estimate of $64.56 million.
What price target have analysts set for INSP?
8 Wall Street analysts have issued 1-year price objectives for Inspire Medical Systems' stock. Their predictions range from $25.00 to $64.00. On average, they anticipate Inspire Medical Systems' share price to reach $41.6250 in the next year. This suggests that the stock has a possible downside of 25.5%. View Analyst Price Targets for Inspire Medical Systems.
What is the consensus analysts' recommendation for Inspire Medical Systems?
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last year. There are currently 1 sell rating, 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Inspire Medical Systems.
Has Inspire Medical Systems been receiving favorable news coverage?
News articles about INSP stock have been trending somewhat positive on Friday, InfoTrie Sentiment reports. The research group rates the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Inspire Medical Systems earned a news sentiment score of 0.8 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 7.0 out of 10, meaning that recent media coverage is likely to have an impact on the stock's share price in the near future.
Who are some of Inspire Medical Systems' key competitors?
Some companies that are related to Inspire Medical Systems include ConvaTec Group (CTEC), Draegerwerk AG & Co KGaA (DRW3), Stratec Biomedical (SBS), Avita Medical (AVH), Helius Medical Technologies (HSM), Creo Medical Group (CREO), Medica Group (MGP), Hamilton Thorne (HTL), Kromek Group (KMK), Titan Medical (TMD), Impedimed (IPD), Cyclopharm (CYC), Advanced Oncotherapy (AVO), REVA Medical (RVA) and Protech Home Medical (PHM).
What other stocks do shareholders of Inspire Medical Systems own?
Who are Inspire Medical Systems' key executives?
Inspire Medical Systems' management team includes the folowing people:
- Mr. Tim Herbert, Chief Exec. Officer and Pres
- Mr. Richard Buchholz, Chief Financial Officer
- Mr. Randy Ban, Sr. VP of Sales and Marketing
- Mr. Sean Cleary, VP of Global Market Devel.
- Mr. Gary A. Goetzke, VP of Health Economics
When did Inspire Medical Systems IPO?
(INSP) raised $75 million in an IPO on Thursday, May 3rd 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs acted as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.
Who are Inspire Medical Systems' major shareholders?
Inspire Medical Systems' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Orbimed Advisors LLC (8.55%), BlackRock Inc. (3.76%), Lord Abbett & CO. LLC (3.65%), Millennium Management LLC (1.28%), Mairs & Power INC (0.73%) and Northern Trust Corp (0.73%). Company insiders that own Inspire Medical Systems stock include Amzak Health Investors, Llc, Casey M Tansey, Jerry C Griffin, Joyce Erony, Marilyn C Nelson, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert. View Institutional Ownership Trends for Inspire Medical Systems.
Which major investors are selling Inspire Medical Systems stock?
INSP stock was sold by a variety of institutional investors in the last quarter, including Orbimed Advisors LLC, Jennison Associates LLC and American Century Companies Inc.. Company insiders that have sold Inspire Medical Systems company stock in the last year include Casey M Tansey, Jerry C Griffin, Joyce Erony, Randy Ban, Richard Buchholz and Timothy P Herbert. View Insider Buying and Selling for Inspire Medical Systems.
Which major investors are buying Inspire Medical Systems stock?
INSP stock was acquired by a variety of institutional investors in the last quarter, including Lord Abbett & CO. LLC, BlackRock Inc., Millennium Management LLC, Kornitzer Capital Management Inc. KS, Castleark Management LLC, Monashee Investment Management LLC, Dimensional Fund Advisors LP and Dimensional Fund Advisors LP. Company insiders that have bought Inspire Medical Systems stock in the last two years include Amzak Health Investors, Llc, Marilyn C Nelson, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert. View Insider Buying and Selling for Inspire Medical Systems.
How do I buy shares of Inspire Medical Systems?
Shares of INSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Inspire Medical Systems' stock price today?
One share of INSP stock can currently be purchased for approximately $55.90.
How big of a company is Inspire Medical Systems?
Inspire Medical Systems has a market capitalization of $1.31 billion.
What is Inspire Medical Systems' official website?
MarketBeat Community Rating for Inspire Medical Systems (NASDAQ INSP)
MarketBeat's community ratings are surveys of what our community members think about Inspire Medical Systems and other stocks. Vote "Outperform" if you believe INSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INSP will underperform the S&P 500 over the long term. You may vote once every thirty days.
